Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018

Autor:	Hesse, Elisabeth M., Shimabukuro, Tom T., Su, John R., Hibbs, Beth F., Dooling, Kathleen L., Goud, Ravi, Lewis, Paige, Ng, Carmen S., Cano, Maria V.
Zdroj:	Morbidity and Mortality Weekly Report, 2019 Feb 01. 68(4), 91-94.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/26588573 Zobrazit plný text záznamu